What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Written on 01/23/2026

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
Read full article